Stereotactic body radiation therapy for oligometastases.

Simon S. Lo, Bin S. Teh, Nina A. Mayr, Thomas E. Olencki, Jian Z. Wang, John C. Grecula, Jiade J. Lu, Robert D. Timmerman

Research output: Contribution to journalArticlepeer-review

35 Scopus citations


There are data in the literature to suggest the presence of an oligometastatic state, and local aggressive therapy of the oligometastases may improve outcomes including survival. Stereotactic body radiation therapy has emerged as one of the local therapy options for oligometastases in various body sites, most commonly in the lung and the liver. Retrospective studies and clinical trials have demonstrated promising results with the use of stereotactic body radiation therapy for oligometastases. However, most of the studies have relatively short follow-up intervals. Longer follow-up is necessary to better define the role of stereotactic body radiation therapy in the management of patients with oligometastases. Given the high propensity for distant progression, the combination of novel systemic therapy and stereotactic body radiation therapy is to be explored.

Original languageEnglish (US)
Pages (from-to)247-254
Number of pages8
JournalDiscovery Medicine
Issue number52
StatePublished - Sep 2010

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Stereotactic body radiation therapy for oligometastases.'. Together they form a unique fingerprint.

Cite this